Rocío Nieves Salgado Sánchez

Doctora en Biología
Specialty:
Hematology and hemotherapy
Serving specialties:
  • Hematología y Hemoterapia
Hospitals where he/she works:
  • Hospital Universitario Fundación Jiménez Díaz
General Information
Experience

Jul 2014-Present: Associate Biologist in the Hematological Cytogenetics Laboratory of the Hematology Department of the Jiménez Díaz Foundation University Hospital, Madrid.

Jul 2012-Jun 2014: Senior Technician in the Molecular Cytogenetics Laboratory of the Spanish National Cancer Research Center (CNIO), Madrid.

Feb 2009-Dec 2011: Researcher in IMIM Foundation, Barcelona.

Jan 2008-Jan 2009: Associate Biologist in the Cytogenetics and Molecular Biology Laboratory, Pathology Department, Hospital del Mar-IMAS, Barcelona.

Dec 2006-Apr 2007: Associate Biologist in the Cytogenetics and Molecular Biology Laboratory, Pathology Department, Hospital del Mar-IMAS, Barcelona.

Degree

PhD in Biology (Universitat Autònoma de Barcelona)

Bachelor of Biology (Universidad de Navarra)

Techniques

Conventional cytogenetics (karyotyping) of peripheral blood, bone marrow, lymph node, and biological fluid samples (pleural effusion, ascitic fluid, etc.)

Separation of CD138+ plasma cells for the study of multiple myeloma

Enrichment of granulocyte population for the study of eosinophilia

Fluorescence in situ hybridization (FISH) with probes for the study of hematological malignancies

Sanger sequencing

Massive sequencing: myeloid panel, lymphoid panel, and TP53 gene panel

Research and teaching

Linfomas agresivos: Interacción entre el genoma tumoral y el microambiente como determinante de la progresión y respuesta a terapia PI16/01294. Ministerio de Ciencia e Innovación. 2017-2019

Estudio molecular integral del linfoma T angioinmunoblástico PI21/01724. Ministerio de Ciencia e Innovación. 2022-2025

Cytogenetics and Molecular biology analyses in hematological neoplasms.

Teaching assistant for the Hematology course in the Medical Degree at the Autonomous University of Madrid.

Supervisor of final degree projects for the Medical Degree at the Autonomous University of Madrid.

Supervisor of a doctoral thesis for the Molecular Biosciences Program at the Faculty of Medicine of the Autonomous University of Madrid.

Internship tutor for the Oncology, Hematology, and Genetics course in the Medical Degree at the Alfonso X el Sabio University.

Professor for the Master's Degree in Molecular Oncology at the Center for Biomedical Studies

Publications

Participation in 26 publications in the last 5 years, the latest being:

SANTONJA C, MORILLO-GILES D, PRIETO-PAREJA E, SOTO-DE OZAETA C, SERRANO-DEL CASTILLO C, SALGADO-SÁNCHEZ R, YI-SHI AWY, MANSO R, RODRÍGUEZ-PINILLA. Leukaemic Presentation of Small-Cell Alk-Positive Anaplastic Large Cell Lymphoma in a Young Woman. Report of a Case with 9-Year Survival. Medicina (Kaunas). 2023 Sep 8;59(9):1628.

SUÁREZ EU, PIRIS MÁ, RODRÍGUEZ-PINILLA SM, GARCÍA JF, LÓPEZ-LORENZO JL, CORNAGO-NAVASCUÉS J, SALGADO-SÁNCHEZ R, CASTAÑO-BONILLA T, MATA-SERNA R, ALONSO-DOMÍNGUEZ JM, LLAMAS P. Progression of myeloproliferative neoplasm with BCR::JAK2 fusion to acute leukemia of ambiguous lineage. Ann Hematol. 2024;103(5):1797-1799.

RAMOS-CILLAN S, LÁINEZ-GONZÁLEZ D, SOLAN L, BLAS C, SALGADO R, CASTAÑO T, CORNAGO J, LLAMAS P, ALONSO-DOMINGUEZ JM. When the devil is in the details: Similarities and differences between WHO and ICC classifications of AML. Leuk Res. 2024;137:107440.

AGUADO JDBM, ALONSO RM, SALGADO RN, BONILLA TC, LEÓN DEL CAMPO M, RODRÍGUEZ PINILLA SM, DÍAZ DE LA PINTA FJ. V217F MYD88 mutation in low-grade B-cell lymphomas with plasmacytic differentiation: a diagnostic challenge, Pathology, https://doi.org/10.1016/ j.pathol.2025.02.006

ATANCE M, SERRANO C, SOTO C, ALONSO-DOMÍNGUEZ JM, BLAS C, MATA R, CASTAÑO T, PERLADO S, ARQUERO T, LÓPEZ-LORENZO JL, PÉREZ MA, ROSADO B, MARTOS R, RIO-MACHÍN A, LLAMAS-SILLERO P, SALGADO RN, SERRANO-LÓPEZ J. Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome. EJHaem 2025 (aceptado para publicación)

Communications and Presentations

Participation in more than 70 conference presentations (posters and oral presentations), the most recent being:

J ZHENG et al . La expresión aleloespecífica se revela como un nuevo mecanismo oncogénico asociado con la progresión de la leucemia mieloide aguda de alto riesgo. LXVI Congreso Nacional de la SEHH. Mallorca, 24-26 Octubre 2024. CO-066. Comunicación oral.

S RAMOS-CAMPOY et al. Caracterización de la longitud telomérica en una cohorte de pacientes con LLC: impacto pronóstico y asociación con otros biomarcadores. LXVI Congreso Nacional de la SEHH, Mallorca, 24-26 Octubre 2024. CO-162. Comunicación oral.

M ATANCE et al. Eventos de TP53 en mieloma múltiple: deleción, mutación o ambos?. CO-004. LXV Congreso Nacional de la SEHH, Sevilla 26-28 Octubre 2023. Comunicación oral.

R SALGADO, et al. Análisis genético y clínico de pacientes con diagnóstico de neoplasia mieloide y mutaciones germinales en DDX41. LXVI Congreso Nacional de la SEHH. Mallorca, 24-26 Octubre 2024.

Awards and certifications

Coordinator of the Spanish Cooperative Group on Hematological Cytogenetics of the Spanish Society of Hematology and Hemotherapy (SEHH)

Member of the Spanish Society of Hematology and Hemotherapy (SEHH)

Member of the Spanish Association of Human Genetics (AEGH)